Olzep 20 mg (Capsule (Enteric Coated))
Unit Price: ৳ 5.00 (60's pack: ৳ 300.00)
Medicine Details
Category | Details |
---|---|
Generic | Omeprazole |
Company | Arges life science limited |
Indications
- Gastric and duodenal ulcer
- NSAID-associated duodenal and gastric ulcer
- As prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
- Gastro-esophageal reflux disease
- Long-term management of acid reflux disease
- Acid-related dyspepsia
- Severe ulcerating reflux esophagitis
- Prophylaxis of acid aspiration during general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori-induced peptic ulcer
Pharmacology
- Inhibitor of gastric acid secretion
- Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
- Onset of antisecretory effect occurs within one hour
- Maximum effect occurs within two hours
- Inhibition of secretion lasts up to 72 hours
- Secretory activity returns gradually over 3 to 5 days after discontinuation
Dosage
- 20 mg once daily for benign gastric and duodenal ulcer
- 40 mg daily for severe or recurrent cases
- 10-20 mg daily for prevention of relapse in duodenal ulcer
- 20 mg once daily for NSAID-associated duodenal or gastric ulcer
- 20 mg once daily for gastro-esophageal reflux disease
- 40 mg once daily for refractory gastro-esophageal reflux disease
- 10-20 mg daily for long-term management of acid reflux disease
- 10-20 mg once daily for acid-related dyspepsia
- 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery for prophylaxis of acid aspiration
- 60 mg once daily for Zollinger-Ellison syndrome
- 20 mg twice daily for Helicobacter pylori eradication regimen in peptic ulcer disease
- 10-20 mg once daily for 4-12 weeks in severe ulcerating reflux esophagitis (Child > 1 year)
- 40 mg for intravenous prophylaxis of acid aspiration
- 40 mg once daily for intravenous treatment of duodenal ulcer, gastric ulcer or reflux esophagitis
- 60 mg daily for Zollinger-Ellison syndrome intravenous treatment
Administration
- Omeprazole is for intravenous administration only
- IV injection should be given slowly over a period of at least 2 to 5 minutes at a maximum rate of 4 ml/minute
- Use only freshly prepared solution for IV injection
- IV infusion should be given over a period of 20-30 minutes or more
- Reconstituted solution should not be mixed or co-administered with any other drug
Interaction
- Decreased intragastric acidity may reduce absorption of ketoconazole
- Metabolised in the liver through cytochrome P450
- Can delay the elimination of diazepam, phenytoin and warfarin
- Plasma concentrations of Olzep and clarithromycin are increased during concomitant administration
- No evidence of interaction with phenacetin, theophylline, caffeine, propranolol, metoprolol, cyclosporin, lidocaine, quinidine, estradiol, amoxycillin, or antacids
- No evidence of interaction with piroxicam, diclofenac or naproxen
- Simultaneous treatment with Olzep and digoxin leads to a 10% increase in the bioavailability of digoxin due to increased intragastric pH
Contraindications
- Known hypersensitivity to Omeprazole
- Suspicion of gastric ulcer with potential malignancy
Side Effects
- Skin rash, urticaria and pruritus
- Photosensitivity, bullous eruption, erythema multiforme, angioedema and alopecia
- Diarrhoea and headache
- Constipation, nausea/vomiting, flatulence and abdominal pain
- Dry mouth, stomatitis and candidiasis
- Paraesthesia, dizziness, light headedness and feeling faint
- Somnolence, insomnia and vertigo
- Reversible mental confusion, agitation, depression and hallucinations
- Arthritic and myalgic symptoms
- Blurred vision, taste disturbance, peripheral oedema, increased sweating, gynaecomastia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, anaphylactic shock, malaise, fever, bronchospasm, encephalopathy, hepatitis with or without jaundice, interstitial nephritis, hepatic failure, increases in liver enzymes
Pregnancy & Lactation
- No adverse effects on pregnancy or on the health of the fetus/newborn child based on epidemiological studies
- Omeprazole can be used during pregnancy
- No information available on the passage of Omeprazole into breast milk or its effects on the neonate
- Breastfeeding should be discontinued if the use of Omeprazole is considered essential
- Safety and effectiveness not established in pediatric patients less than 18 years of age
Precautions & Warnings
- Avoid concomitant use of clopidogrel and Omeprazole
- Increased risk for osteoporosis-related fractures with PPI therapy
- Atrophic gastritis noted occasionally in gastric corpus biopsies from long-term treated patients
- Concomitant use of PPIs with methotrexate may lead to methotrexate toxicities
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Keep in a dry place away from light and heat
- Keep out of the reach of children
Related Brands
- Regerd 40 mg/vial (IV Injection) - novatek-pharmaceuticals-ltd
- Omehil 20 mg (Capsule (Enteric Coated)) - goodman-pharmaceuticals-ltd
- Omehil 40 mg (Capsule (Enteric Coated)) - goodman-pharmaceuticals-ltd
- Prazover 40 mg (Capsule (Enteric Coated)) - veritas-pharmaceuticals-ltd
- Omsec 40 mg (Capsule (Enteric Coated)) - techno-drugs-ltd